Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

Summary

The primary objective of this study is to compare the rate of healing as well as percent of wounds healed in Type II diabetic patients with chronic foot ulcerations receiving sitagliptin versus placebo. The hypothesis for this study is that subjects receiving daily doses of sitagliptin in combination with their regular antihyperglycemic medications will result in increased healing rates as well as a greater number of healed wounds as compared to subjects receiving placebo and their regular antihyperglycemic medications.

Timeline

Start

2014-01

Primary completion

2015-01

Completion

2015-01

Drugs

Indications